| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.9 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.0087 | 0.9 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.0055 | 0.9 |